                         SEQUENCE LISTING

<110>  Tufts Medical Center
       Kayyali, Usamah S.
 
<120>  Compounds and Methods for Augmenting Permeability Barriers

<130>  NEMCH-32082/WO-1/ORD

<140>  PCT/US 2012/051051
<141>  2012-08-16

<150>  US 61/524,537
<151>  2011-08-17

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

His Pro Arg Asn Pro Ala Arg Arg Thr Pro Gly Thr Arg Arg Gly Ala 
1               5                   10                  15      


Pro Ala Ala 
            


<210>  2
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  3
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Tyr Ala Arg Lys Ala Arg Arg Gln Ala Arg Arg 
1               5                   10      


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4

Tyr Gly Arg Lys Lys Arg Arg Gln Arg 
1               5                   


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Cys 
1               5                   10                  


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  8
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala His Pro Arg Asn Pro 
1               5                   10                  15      


Ala Arg Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala Ala 
            20                  25                  30  


<210>  9
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9

Tyr Ala Arg Lys Ala Arg Arg Gln Ala Arg Arg His Pro Arg Asn Pro 
1               5                   10                  15      


Ala Arg Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala Ala 
            20                  25                  30  


<210>  10
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10

Tyr Gly Arg Lys Lys Arg Arg Gln Arg His Pro Arg Asn Pro Ala Arg 
1               5                   10                  15      


Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala Ala 
            20                  25              


<210>  11
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg His Pro Arg Asn Pro 
1               5                   10                  15      


Ala Arg Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala Ala 
            20                  25                  30  


<210>  12
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Cys His Pro 
1               5                   10                  15      


Arg Asn Pro Ala Arg Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala 
            20                  25                  30          


Ala 
    


<210>  13
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  13

Arg Arg Arg Arg Arg Arg Arg Arg Arg His Pro Arg Asn Pro Ala Arg 
1               5                   10                  15      


Arg Thr Pro Gly Thr Arg Arg Gly Ala Pro Ala Ala 
            20                  25              


